Quick Answer
Eledon Pharmaceuticals, Inc. reported Shares Outstanding of 75.43 million shares for fiscal year 2025.
Eledon Pharmaceuticals, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 75.43M | +26.2% |
| 2024 | 59.79M | +146.9% |
| 2023 | 24.21M | +75.8% |
| 2022 | 13.78M | -3.7% |
| 2021 | 14.31M | -5.6% |
| 2020 | 15.16M | +2004.4% |
| 2019 | 720,408 | -92.4% |
| 2018 | 9.42M | +32.5% |
| 2017 | 7.11M | +1703.3% |
| 2016 | 394,306 | -98.3% |
| 2015 | 22.60M | +1.0% |
| 2014 | 22.38M | +4437.3% |
| 2013 | 493,292 | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 59.88M | +45.4% | +0.0% |
| June 30, 2025 | 59.88M | +55.5% | +0.0% |
| March 31, 2025 | 59.88M | +141.3% | +0.2% |
| December 31, 2024 | 59.79M | +146.9% | +45.2% |
| September 30, 2024 | 41.18M | +74.9% | +7.0% |
| June 30, 2024 | 38.51M | +67.1% | +55.2% |
| March 31, 2024 | 24.81M | +80.1% | +2.5% |
| December 31, 2023 | 24.21M | +75.8% | +2.8% |
- Eledon Pharmaceuticals, Inc. showed an increase of +26.2% in Shares Outstanding compared to the prior fiscal year.
- Over the 2013–2025 period, Eledon Pharmaceuticals, Inc.’s shares outstanding has grown by 15191.2% (from 493.3 thousand shares to 75.43 million shares).
- The most recent figure is from Eledon Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: